Is the Options Market Predicting a Spike in Accelerant Stock?
Investors need to pay close attention to ARX stock based on the movements in the options market lately.
Zacks Investment Research10/8/2026Neutral
ARX
Accelerant HoldingsNYSEFINANCIAL SERVICESINSURANCE BROKERS
Key Statistics
Market Cap
$4.29B
P/E Ratio
—
EPS
$-6.22
Beta
—
52W High
$19.90
52W Low
$9.18
50-Day MA
$19.16
200-Day MA
$14.78
Dividend Yield
—
Profit Margin
-127.50%
Forward P/E
22.22
PEG Ratio
—
About Accelerant Holdings
Accelerant Holdings (ARX) is an innovative specialty insurance and reinsurance provider committed to serving underserved markets with a collaborative membership model. Utilizing advanced data analytics and cutting-edge technology, the company enhances underwriting performance and fosters innovation in risk management alongside its insurance partners. This strategic framework allows Accelerant to agilely adapt to the evolving insurance landscape, thereby positioning itself for sustained long-term growth anchored in operational excellence.
Fundamentals
| Revenue (TTM) | $1.07B |
| Gross Profit (TTM) | $697.30M |
| EBITDA | $109.40M |
| Operating Margin | 15.60% |
| Return on Equity | -222.00% |
| Return on Assets | 0.54% |
| Revenue/Share (TTM) | $4.93 |
| Book Value | $3.31 |
| Price-to-Book | 5.99 |
| Price-to-Sales (TTM) | 4.00 |
| EV/Revenue | 2.404 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 800.00% |
| Quarterly Revenue Growth (YoY) | 57.20% |
| Shares Outstanding | $118.55M |
| Float | $56.79M |
| % Insiders | 48.74% |
| % Institutions | 60.76% |
Historical Volatility
HV 10-Day
1.77%
HV 20-Day
2.86%
HV 30-Day
4.37%
HV 60-Day
88.43%
HV Rank
0.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($20.25 target)
5
Hold1
Strong SellLatest News
ACCELERANT HOLDINGS INVESTOR ALERT: Julie & Holleman Investigates Proposed Sale of Accelerant Holdings to Thoma Bravo Over Conflicts Involving Controlling Shareholder
NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Julie & Holleman LLP, a law firm representing investors in securities and corporate governance matters, is investigating the proposed sale of Accelerant Holdings (NYSE: ARX) to private equity firm Thoma Bravo for $20.25 per share.
GlobeNewsWire9/14/2026Neutral
Accelerant's Take-Private Deal Raises a Bigger Question for Insurance Stocks
Accelerant Holdings NYSE: ARX jumped into view for investors in mid-August after its shares surged 43% in a single day. This type of share price leap is often reserved for clinical-stage biotech firms announcing breakthrough results, for instance, not for an unglamorous firm connecting specialty insurance risk across a network of capital providers.
MarketBeat9/4/2026Positive
After Golden Cross, Accelerant Holdings (ARX)'s Technical Outlook is Bright
Accelerant Holdings (ARX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ARX's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Zacks Investment Research8/21/2026Positive
Why Is Accelerant Going Private Just One Year After Its IPO?
ARX is going private just over a year after its IPO, as Thoma Bravo's $4 billion deal capitalizes on stronger operating results.
Zacks Investment Research8/17/2026Positive
Accelerant Q2 Earnings Beat Estimates on Strong Premium Growth
ARX's Q2 earnings beat estimates as premium growth, higher fee revenues and stronger Exchange Services drive results.
Zacks Investment Research8/13/2026Positive
Shareholder Alert: Ademi LLP investigates whether Accelerant Holdings is obtaining a Fair Price for Public Shareholders
MILWAUKEE, Aug. 13, 2026 /PRNewswire/ -- Ademi LLP is investigating Accelerant (NYSE: ARX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Thoma Bravo. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
PRNewsWire8/13/2026Neutral
Accelerant Holdings (ARX) Reports Q2 Earnings: What Key Metrics Have to Say
The headline numbers for Accelerant Holdings (ARX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research8/13/2026Positive
Accelerant Holdings, CorMedix, Birkenstock And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Nasdaq Composite gaining around 200 points on Thursday.
Benzinga8/13/2026Neutral
Accelerant Holdings (ARX) Tops Q2 Earnings and Revenue Estimates
Accelerant Holdings (ARX) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.14 per share a year ago.
Zacks Investment Research8/13/2026Positive
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ARX and any ticker you trade — then tracks every position and per-strategy win rate.
More FINANCIAL SERVICES Stocks
Data last updated: 10/17/2026